PVCT CEO corrects Form 4 preferred share holdings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PROVECTUS BIOPHARMACEUTICALS, INC. director and CEO Edward Pershing filed an updated Form 4 that corrects a past reporting error rather than recording a new transaction. The filing adjusts his reported holdings of Series D-1 Convertible Preferred Stock, with the footnote stating the change "does not reflect a transaction."
After this correction, Pershing is shown holding 2,866,761 shares of Series D-1 Convertible Preferred Stock. Each preferred share is convertible into 10 shares of common stock and will automatically convert into common stock on December 31, 2028, unless converted earlier under the certificate of designation terms.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Series D-1 Convertible Preferred Stock | 45,860 | $0.00 | $0.00 |
Footnotes (3)
- F1. Each share of Series D-1 Preferred Stock is convertible into 10 shares of the Issuer's common stock, par value $0.001 per share ("Common Stock").
- F2. The Series D-1 Convertible Preferred Stock will automatically convert into Common Stock on December 31, 2028, unless earlier converted into Common Stock in accordance with the terms of the Certificate of Designation for the Series D-1 Convertible Preferred Stock.
- F3. The amount reported reflects an adjustment to correct a typographical error in a previously filed Form 4. This adjustment does not reflect a transaction by the Reporting Person.
Key Figures
Key Terms
Series D-1 Convertible Preferred Stock financial
Common Stock financial
Certificate of Designation regulatory
automatic conversion financial
par value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Edward Pershing report in this PVCT Form 4 filing?
When will PVCT’s Series D-1 Convertible Preferred Stock automatically convert to common stock?
What is the conversion ratio for PVCT’s Series D-1 Convertible Preferred Stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.